公司概述
LifeStance Health Group, Inc. operates as a provider of outpatient mental health services across the United States, catering specifically to children, adolescents, adults, and geriatric patients through its subsidiary network. The company functions within the healthcare sector, specifically classified under the medical care facilities industry, positioning itself to serve a critical segment of the population requiring psychiatric evaluations and treatment. Currently, the entity commands a market capitalization of $2.48 billion while generating annual revenue of $1.42 billion and employing a workforce of 10,961 individuals. These valuation and revenue figures indicate that the company has established a substantial market presence, reflecting significant operational scale in the specialized mental health care landscape.
财务健康
The company reported a total revenue of $1.42 billion over the trailing twelve months, with a net income of $9.66 million and an EBITDA of $79.92 million. The substantial gap between the $1.42 billion in revenue and the $9.66 million in net income reveals a cost structure characterized by significant operating expenses relative to top-line growth. The entity generated $112.90 million in free cash flow, which provides the necessary financial flexibility to fund operations, invest in facility expansion, or manage liquidity needs without immediate reliance on external financing. Profitability is defined by a gross margin of 32.4%, an operating margin of 4.7%, and a profit margin of 0.7%, indicating that while revenue collection is efficient, the conversion of revenue to bottom-line profit is heavily impacted by operating costs. On the balance sheet, the company holds $248.64 million in cash against $474.52 million in total debt, resulting in a debt-to-equity ratio of 31.20, which suggests a leveraged financial position rather than a conservative one. Liquidity is supported by a current ratio of 1.65, indicating that current assets are sufficient to cover short-term liabilities with a comfortable buffer. Return on equity stands at 0.7% and return on assets is also 0.7%, metrics that reveal management effectiveness is currently constrained by the high capital base relative to the thin profit margins.
估值评估
The trailing twelve-month P/E ratio is 324.50, whereas the forward P/E is 16.97, implying that the market expects a significant improvement in earnings trajectory to justify the current multiple. The price-to-book ratio is 1.66, indicating that the market is willing to pay a premium over the company's net asset value, potentially reflecting growth expectations despite current profitability challenges. Alternative valuation metrics such as a price-to-sales ratio of 1.74 and an EV/EBITDA of 34.48 suggest that investors are pricing the stock based on revenue and cash generation capabilities rather than current earnings power. The stock has traded between a 52-week high of $8.09 and a 52-week low of $3.74, with the current price position relative to this range serving as a reference point for volatility analysis. The beta value is 1.13, which means the stock price exhibits volatility that is slightly higher than the broader market, making it more sensitive to general market fluctuations.
Growth & Income
Revenue growth year-over-year stands at 17.4%, while earnings growth is marked as N/A, indicating that the company is currently expanding its top line faster than its ability to translate that expansion into reported earnings growth. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the entity reinvests all available earnings back into the business for growth rather than distributing income to shareholders. This strategy of retaining earnings supports capital-intensive growth in the mental health services sector but limits immediate income returns for investors seeking yield. Overall, the growth and income profile is defined by strong revenue expansion and a complete reinvestment of profits, with no current cash distribution to shareholders.